Abstract:BACKGROUND:Galangin is one of the flavonoids in Alpinia officinarum. It has various anti-tumor activities, but its anti-bladder cancer effect is unclear.OBJECTIVE:To investigate the mechanism of action of galangin against bladder cancer using a network pharmacology approach.METHODS:The TCM Systematic Pharmacology Database and Analysis Platform (TCMSP), SwissTargetPrediction database, and the Targetnet database were used to predict the targets of action of galangin. Bladder cancer-related targets were obtained through the GeneCards database. The intersection of the two was taken as the target of galangin's action against bladder cancer. The intersecting targets were screened for core targets using the STRING database and Cytoscape 3.9.0 software to build a protein-protein interaction (PPI) network of targets. The core targets were subjected to gene ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis using the online annotation and visual integration analysis tool DAVIDBioinformaticsResources (2021Update). A drug-disease-target-pathway network was constructed using Cytoscape 3.9.0 software. The antibladder cancer effect of galangin was observed by cell proliferation, and plate cloning assay; apoptosis of bladder cancer cells induced by galangin was detected by Hoechst33342 staining and flow cytometry; protein immunoblotting (Western-blot) was used to detect the effect of galangin on apoptosis-related proteins Bax, Bcl-2, Cleaved-PARP, p53 signaling pathway p53 and cytc.RESULTS:A total of 115 genes were obtained from galangin against bladder cancer, and 16 core targets were screened. The kEGG pathway enrichment analysis included Pathways in cancer, PI3K-AKT signaling pathway, p53 signaling pathway, etc. In vitro experiments showed that galangin could inhibit bladder cancer cell proliferation, induce apoptosis, upregulate the expression of apoptosis-related proteins Bax and Cleaved-PARP and downregulate the expression of Bcl-2; meanwhile, galangin could promote the upregulation of the expression of p53 and cytc proteins by activating the p53 signaling pathway.CONCLUSION:Galangin induced apoptosis in bladder cancer cells by activating the p53 signaling pathway.

Galangin Induced Antitumor Effects in Human Kidney Tumor Cells Mediated Via Mitochondrial Mediated Apoptosis, Inhibition of Cell Migration and Invasion and Targeting PI3K/ AKT/mTOR Signalling Pathway.

Galangin, A Flavonoid From Lesser Galangal, Induced Apoptosis Via P53-Dependent Pathway In Ovarian Cancer Cells

Dietary Compounds Galangin and Myricetin Suppress Ovarian Cancer Cell Angiogenesis

Galangin Inhibits Programmed Cell Death-Ligand 1 Expression by Suppressing STAT3 and MYC and Enhances T Cell Tumor-Killing Activity.

Galangin Increases ERK 1 / 2 Phosphorylation to Decrease ADAM 9 Expression and Prevents Invasion in A 172 Glioma Cells

Network-based Pharmacology and in Vitro Validation Reveal That Galangin Induces Apoptosis in Bladder Cancer Cells by Promoting the P53 Signaling Pathway.

Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells

Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition

Galangin Inhibits Tumor Growth and Metastasis of B16f10 Melanoma

Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK

Galangin Induces Apoptosis on Lung Cancer A549 Cells

In Vitro Effects and the Related Molecular Mechanism of Galangin and Quercetin on Human Gastric Cancer Cell Line (SGC-7901).

Galangin induces apoptosis of glioma cells through Wnt/β-Catenin signal pathway

Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production

Galangin and TRAIL cooperate to suppress A549 lung cancer proliferation via apoptosis and p38 MAPK activation

Polyphenol Galangin Induces the ROS and ER Stress-Mediated Intrinsic and Extrinsic Apoptotic Pathways Towards Human Colon Carcinoma HCT-116 Cells

Galangin enhances gold nanoparticles as anti-tumor agents against ovarian cancer cells

Insights into the anticancer effects of galangal and galangin: A comprehensive review

Galangin (GLN) Promotes Temozolomide-Induced Apoptosis in Glioma Cells

Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)

The Natural Flavonoid Galangin Elicits Apoptosis, Pyroptosis, and Autophagy in Glioblastoma.